AstraZeneca | Cafepharma
4 days ago · After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a particular type of breast cancer, the companies …
AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device …
Aug 1, 2022 · Anonymous board for AstraZeneca.
AstraZeneca | Cafepharma
Dec 10, 2025 · AstraZeneca’s Imfinzi can now be used to treat patients with gastric and gastroesophageal junction cancers as part of a chemotherapy combination, adding another …
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales
Cafepharma News
Latest news and updates on pharmaceutical and medical sales, including breakthrough treatments and industry trends.
Cafepharma - Home | pharma sales, device sales, lab sales
3 days ago · Pfizer foresees challenging 2026 on fading COVID sales, margin pressure Pfizer board Caris signs Genentech deal worth up to $1.1 billion for rare cancer targets Genentech …
AstraZeneca's latest amyloidosis pact with Neurimmune could …
Dec 4, 2025 · Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to pick up a second asset. The latest licensing deal involves NI009, …
GlaxoSmithKline | Cafepharma Message Boards | Pharma Sales, …
Aug 17, 2014 · Anonymous board for GlaxoSmithKline
Pfizer | Cafepharma Message Boards | Pharma Sales, Device Sales, …
Feb 23, 2025 · Anonymous board for Pfizer.
Pharma/Biotech Companies | Cafepharma Message Boards
Jul 19, 2015 · Anonymous discussion boards for pharmaceutical and biotech companies